Operating Lease, Right-of-Use Asset of Solid Biosciences Inc. from 01 Jan 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Solid Biosciences Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 01 Jan 2019 to 30 Sep 2025.
  • Solid Biosciences Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $22,535,000, a 9.3% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Solid Biosciences Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $22,535,000 -$2,324,000 -9.3% 30 Sep 2025 10-Q 03 Nov 2025 2025 Q3
Q2 2025 $23,133,000 -$2,375,000 -9.3% 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $23,720,000 -$2,378,000 -9.1% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $24,295,000 -$2,244,000 -8.5% 31 Dec 2024 10-Q 03 Nov 2025 2025 Q3
Q3 2024 $24,859,000 -$2,330,000 -8.6% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 $25,508,000 -$2,333,000 -8.4% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 $26,098,000 -$2,208,000 -7.8% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 $26,539,000 -$2,410,000 -8.3% 31 Dec 2023 10-K 06 Mar 2025 2024 FY
Q3 2023 $27,189,000 -$1,255,000 -4.4% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 $27,841,000 -$1,098,000 -3.8% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $28,306,000 +$27,584,000 +3820% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $28,949,000 +$27,807,000 +2435% 31 Dec 2022 10-K 13 Mar 2024 2023 FY
Q3 2022 $28,444,000 +$27,226,000 +2235% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $28,939,000 +$27,358,000 +1730% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 $722,000 -$2,474,000 -77% 31 Mar 2022 10-Q 27 Apr 2022 2022 Q1
Q4 2021 $1,142,000 -$2,437,000 -68% 31 Dec 2021 10-K 23 Mar 2023 2022 FY
Q3 2021 $1,218,000 -$2,733,000 -69% 30 Sep 2021 10-Q 03 Nov 2021 2021 Q3
Q2 2021 $1,581,000 -$2,729,000 -63% 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 $3,196,000 -$1,459,000 -31% 31 Mar 2021 10-Q 14 May 2021 2021 Q1
Q4 2020 $3,579,000 -$1,409,000 -28% 31 Dec 2020 10-K 14 Mar 2022 2021 FY
Q3 2020 $3,951,000 -$1,578,000 -29% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $4,310,000 -$1,308,000 -23% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 $4,655,000 -$1,261,000 -21% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $4,988,000 +$388,000 +8.4% 31 Dec 2019 10-K 15 Mar 2021 2020 FY
Q3 2019 $5,529,000 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 $5,618,000 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 $5,916,000 31 Mar 2019 10-Q 13 May 2019 2019 Q1
Q4 2018 $4,600,000 01 Jan 2019 10-K 15 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.